Keyphrases
Arbovirus
16%
Brazil
33%
Chromatography
16%
Clinical Outcomes
16%
Co-circulation
100%
Comorbidity
16%
Cough
16%
COVID-19
100%
COVID-19 Patients
16%
Dengue
100%
Dengue Epidemic
16%
Dengue Patients
16%
DENV Infection
33%
DENV NS1
16%
Diabetes
16%
Dyspnea
16%
Fever
33%
High Mortality Rate
16%
Hospital Care
16%
Hospitalization
16%
Hospitalized Patients
100%
IgM Antibody
16%
Impact on Patients
16%
Infected Patients
16%
Infectious Diseases
16%
Intensive Care Unit Stay
16%
Interleukin-10
16%
Interleukin-1β
16%
Laboratory Confirmation
16%
Mechanical Ventilatory Support
16%
Molecular Assay
16%
Neotropics
16%
Neutralizing Antibodies
16%
Past Exposure
16%
Patient Management
16%
Public Health Resources
16%
Recent Infection
16%
Respiratory Distress
16%
Secondary Dengue
33%
Serology Assays
16%
Serum Samples
16%
Subsequent Infection
16%
Tropical Countries
16%
Tropics
16%
Medicine and Dentistry
Arbovirus
9%
Comorbidity
9%
Coughing
9%
COVID-19
18%
Dengue Fever
100%
Dengue Virus
100%
Diabetes
9%
Diseases
9%
Dyspnea
9%
Enzyme Linked Immunosorbent Assay
9%
Immunoglobulin M
18%
Immunoglobulin M Antibody
9%
Infection
100%
Infectious Disease
9%
Intensive Care Unit
9%
Interleukin 1
9%
Interleukin 10
9%
Mortality Rate
9%
Neutralizing Antibody
9%
Patient Care
9%
Public Health
9%
Respiratory Distress
9%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Tumor Necrosis Factor
9%
Pharmacology, Toxicology and Pharmaceutical Science
Arbovirus
9%
Comorbidity
9%
Coronavirinae
9%
Coughing
9%
Dengue
100%
Dengue Virus
100%
Diseases
27%
Dyspnea
9%
Enzyme-Linked Immunosorbent Assay
9%
Immunoglobulin M
18%
Immunoglobulin M Antibody
9%
Infection
100%
Interleukin 1
9%
Interleukin 10
9%
Mortality Rate
9%
Neutralizing Antibody
9%
Respiratory Distress
9%
SARS Coronavirus
100%
Tumor Necrosis Factor
9%
Immunology and Microbiology
Arbovirus
9%
Chromatography
9%
Comorbidity
9%
COVID-19
18%
Dengue Fever
100%
Dengue Virus
100%
ELISA
9%
Immunoglobulin M
18%
Immunoglobulin M Antibody
9%
Infection
100%
Interleukin 1
9%
Interleukin 10
9%
Mortality Rate
9%
Neutralizing Antibody
9%
Serology
9%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Tumor Necrosis Factor
9%